ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 2035

$581K Total Retail Price of All Prescriptions

Rank: 212 out of 2035

394 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

54% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

5% of this provider’s 4,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,079 383 S3 1 2
OXYCODONE HCL 516 161 S2 2 62
LISINOPRIL 409 185 3 3
CARISOPRODOL 362 87 R 4 57
PROAIR HFA 320 89 5 31
AMLODIPINE BESYLATE 306 146 6 6
SIMVASTATIN 301 143 7 1
OMEPRAZOLE 266 132 8 5
METOPROLOL TARTRATE 241 132 9 8
RANITIDINE HCL 218 98 10 28
HYDROCHLOROTHIAZIDE 198 101 11 12
ACETAMINOPHEN-CODEINE 184 75 S3 12 52
METFORMIN HCL 165 71 13 9
FUROSEMIDE 164 97 14 7
CYCLOBENZAPRINE HCL 128 48 R 15 64
CLONIDINE HCL 125 24 16 61
VENTOLIN HFA 125 15 16 80
AMOXICILLIN 122 39 18 116
PROMETHAZINE HCL 121 27 R 19 106
GABAPENTIN 120 39 20 14
LIDODERM 103 32 21 72
ZOLPIDEM TARTRATE 103 56 21 21
TAMSULOSIN HCL 95 45 23 25
ADVAIR DISKUS 92 14 24 38
ISOSORBIDE MONONITRATE ER 91 63 25 32
ATORVASTATIN CALCIUM 91 67 25 13
POTASSIUM CHLORIDE 90 36 27 18
OXYCONTIN 89 28 S2 28 152
ATENOLOL 88 46 29 10
FLUTICASONE PROPIONATE 85 24 30 29
NIFEDIPINE ER 81 59 31 98
SPIRIVA 80 19 32 44
CLOPIDOGREL 79 45 33 30
OPANA ER 77 15 S2 34 172
GLIPIZIDE 74 41 35 54
PLAVIX 71 40 36 49
TRAMADOL HCL 68 0 37 19
NEXIUM 66 14 38 51
IBUPROFEN 63 21 39 43
AMMONIUM LACTATE 63 26 39 155
HYDRALAZINE HCL 62 41 41 45
ENALAPRIL MALEATE 61 32 42 60
NAPROXEN 60 39 43 92
BETAMETHASONE VALERATE 58 12 44 191
WARFARIN SODIUM 57 41 45 11
PENTOXIFYLLINE 56 33 46 285
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 13 47 26
CARVEDILOL 52 16 48 22
DETROL LA 50 22 49 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.